Total Payments
$30,952
2024 Payments
$95.00
Companies
8
Transactions
50
Payment Breakdown by Category
Consulting$27,606 (89.2%)
Travel$1,633 (5.3%)
Food & Beverage$1,596 (5.2%)
Education$115.85 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $27,606 | 9 | 89.2% |
| Travel and Lodging | $1,633 | 11 | 5.3% |
| Food and Beverage | $1,596 | 27 | 5.2% |
| Education | $115.85 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $20,704 | 17 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $5,543 | 18 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $3,000 | 1 | $0 (2018) |
| Vertex Pharmaceuticals Incorporated | $1,310 | 7 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $230.04 | 4 | $0 (2024) |
| Olympus America Inc. | $125.78 | 1 | $0 (2020) |
| GlaxoSmithKline, LLC. | $23.09 | 1 | $0 (2017) |
| Respiratory Technologies, Inc. | $16.01 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $95.00 | 1 | Regeneron Healthcare Solutions, Inc. ($95.00) |
| 2023 | $460.00 | 1 | Vertex Pharmaceuticals Incorporated ($460.00) |
| 2022 | $940.89 | 8 | Vertex Pharmaceuticals Incorporated ($805.85) |
| 2021 | $5,000 | 1 | Gilead Sciences, Inc. ($5,000) |
| 2020 | $125.78 | 1 | Olympus America Inc. ($125.78) |
| 2019 | $9,859 | 15 | Gilead Sciences, Inc. ($5,277) |
| 2018 | $8,432 | 9 | Gilead Sciences, Inc. ($5,198) |
| 2017 | $6,039 | 14 | Gilead Sciences Inc ($5,228) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $95.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/25/2023 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $460.00 | General |
| 10/12/2022 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $230.00 | General |
| 05/16/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $72.40 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/16/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $50.22 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/16/2022 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $460.00 | General |
| 03/08/2022 | Vertex Pharmaceuticals Incorporated | TRIKAFTA (Drug) | Education | In-kind items and services | $43.95 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 03/08/2022 | Vertex Pharmaceuticals Incorporated | TRIKAFTA (Drug) | Education | In-kind items and services | $43.95 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 03/08/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/07/2022 | Vertex Pharmaceuticals Incorporated | — | Education | In-kind items and services | $27.95 | General |
| 04/07/2021 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| 01/21/2020 | Olympus America Inc. | Digital Recording Devices (Device) | Food and Beverage | In-kind items and services | $125.78 | General |
| Category: Surgical Endoscopy | ||||||
| 10/30/2019 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| 10/30/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $113.92 | General |
| 10/27/2019 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Consulting Fee | Cash or cash equivalent | $3,456.00 | General |
| 10/27/2019 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Travel and Lodging | In-kind items and services | $342.30 | General |
| 10/27/2019 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Travel and Lodging | Cash or cash equivalent | $56.00 | General |
| 10/27/2019 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Travel and Lodging | Cash or cash equivalent | $43.20 | General |
| 10/27/2019 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Food and Beverage | In-kind items and services | $32.60 | General |
| 10/27/2019 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Food and Beverage | In-kind items and services | $22.00 | General |
| 10/26/2019 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $543.00 | General |
| 10/26/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $86.67 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/23/2019 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $28.00 | General |
| 09/20/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 09/20/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $30.00 | General |
About Dr. Pamela Zeitlin, M.D
Dr. Pamela Zeitlin, M.D is a Pediatric Pulmonology healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346278801.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pamela Zeitlin, M.D has received a total of $30,952 in payments from pharmaceutical and medical device companies, with $95.00 received in 2024. These payments were reported across 50 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($27,606).
Ad
Practice Information
- Specialty Pediatric Pulmonology
- Other Specialties Pediatric Pulmonology
- Location Denver, CO
- Active Since 06/30/2006
- Last Updated 03/17/2021
- Taxonomy Code 2080P0214X
- Entity Type Individual
- NPI Number 1346278801
Products in Payments
- FASENRA (Drug) $3,000
- FEVIPIPRANT (Drug) $493.51
- DUPIXENT (Biological) $230.04
- Digital Recording Devices (Device) $125.78
- TRIKAFTA (Drug) $87.90
- ENTRESTO (Drug) $86.67
- QAW (Drug) $72.11
- NUCALA (Biological) $23.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Pulmonology Doctors in Denver
Matthew Mcgraw, Md, MD
Pediatric Pulmonology — Payments: $2,892
Pediatric Pulmonology $2,892
Jane Gross, Md, MD
Pediatric Pulmonology — Payments: $1,475
Pediatric Pulmonology $1,475
Dr. James Brock, D.o, D.O
Pediatric Pulmonology — Payments: $1,445
Pediatric Pulmonology $1,445
Lee Rusakow, Md, MD
Pediatric Pulmonology — Payments: $372.84
Pediatric Pulmonology $372.84